Human IgG2 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61986r |
| Product Name | Human IgG2 Recombinant Antibody |
| Applications |
WB
IHC-P
IHC-F
IF(IHC-P)
IF(ICC)
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human Human IgG2 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Swiss Prot | P01859 |
| Synonyms | IGHG2; immunoglobulin Gm2; immunoglobulin heavy constant gamma 2 (G2m marker). |
| Background | Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens |
| Application Dilution | |
| WB | 1:500-2000 |
| IHC-P | IHC-P1:500-2000 |
| IHC-F | IHC-F1:500-2000 |
| IF(IHC-P) | IFIHC-P1:500-2000 |
| IF(ICC) | IFICC1:100-500 |